"Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for " by Minesh Mehta

Menu

Skip to main content

All Publications

Minesh Mehta, Miami Cancer InstituteFollow

Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424

Publication Date

2020

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

International Journal of Radiation Oncology, Biology, Physics (2020) 107(4):720-725

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS